Open access
Tissue and imaging biomarkers in the treatment of NSCLC
Characteristics of the tumor immune microenvironment and PET imaging of PD-1/PD-L1 have potential as biomarkers for immunotherapy in NSCLC are demonstrated and larger studies are required to validate the predictive value of these approaches.
A. Niemeijer
· 0 citations